Shanghai Junshi Biosciences Co Ltd
SSE:688180
Relative Value
The Relative Value of one Shanghai Junshi Biosciences Co Ltd stock under the Base Case scenario is 39.34 CNY. Compared to the current market price of 30.14 CNY, Shanghai Junshi Biosciences Co Ltd is Undervalued by 23%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Shanghai Junshi Biosciences Co Ltd Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
CN |
S
|
Shanghai Junshi Biosciences Co Ltd
SSE:688180
|
29.7B CNY | 19.8 | -13 | -11.1 | -11.1 | |
US |
Abbvie Inc
NYSE:ABBV
|
285.5B USD | 5.3 | 59.3 | 12.9 | 19.6 | ||
US |
Amgen Inc
NASDAQ:AMGN
|
146.7B USD | 5.2 | 21.9 | 16.3 | 24.4 | ||
US |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
101.8B USD | 10.3 | 28.1 | 22.4 | 23.5 | ||
US |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
98B USD | 7.5 | 24.7 | 16.4 | 18 | ||
AU |
CSL Ltd
ASX:CSL
|
133.7B AUD | 6.2 | 35.5 | 21.5 | 26.7 | ||
US |
Gilead Sciences Inc
NASDAQ:GILD
|
80.9B USD | 3 | 14.4 | 7.9 | 10.1 | ||
US |
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | ||
US |
Moderna Inc
NASDAQ:MRNA
|
42.8B USD | 6.3 | -9.1 | -9.6 | -8.2 | ||
US |
Biogen Inc
NASDAQ:BIIB
|
31.4B USD | 3.2 | 27.1 | 14.6 | 18.1 | ||
KR |
Celltrion Inc
KRX:068270
|
39.2T KRW | 18 | 73.1 | 44.7 | 61.6 |